Dr. Rezak Drali is an R&D Engineer at ABL Diagnostics, specializing in molecular diagnostics, pathogen genomics, and next-generation sequencing (NGS) technologies. He holds a PhD in Infectious Diseases. He contributes to the development, optimization, and validation of sequencing-based assays and bioinformatics solutions for infectious disease diagnostics and antimicrobial resistance surveillance. His work focuses on pathogen identification, genotyping, genomic epidemiology, and the implementation of innovative sequencing workflows in clinical and public health settings. He has co-authored peer-reviewed publications in the fields of microbiology, infectious diseases, and genomic surveillance. His research interests include clinical microbiology, antimicrobial resistance, pathogen genomics, and the application of NGS technologies to improve routine diagnostic practice.